Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
42 Cards in this Set
- Front
- Back
True or false: the onset and offset of SVT are both gradual.
|
False.
Usually sudden onset and offset - this differentiates SVT from sinus tachycardia, which is gradual. |
|
List common symptoms of SVT
|
palpitations
heart-racing chest discomfort dyspnea |
|
Describe the mechanism of reentry in AVNRT.
|
Two pathways - one fast conducting with long RP and one slow conducting with short RP.
Premature beat hits AV node, makes the fast pathway refractory because it has fallen within this pathway's RP. Impulse goes through slow pathway, and if the tissue in the fast pathway has recovered and is no longer refractory, re-entry occurs. |
|
What is pre-excitation and how does it manifest on ECG?
|
Activation of ventricles via accessory pathway BEFORE the AV node has conducted its impulse.
Appears on ECG as a delta wave, slurred QRS, and short PR interval. |
|
True or false: accessory pathways only conduct impulses in a forward direction towards the ventricles.
|
False.
Most conduct both ways, but there are some that conduct only forwards or only retrograde. You need to have forward conduction for pre-excitation to occur. |
|
What is Wolfe Parkinson White syndrome?
|
A syndrome in which there is evidence of pre-excitation via accessory pathway and symptoms of tachyarrhythmia.
|
|
How does reentry occur in orthodromic AVRT? What does the QRS complex look like on ECG?
|
Impulse does not conduct through the accessory pathway because it is refractory.
Impulse conducts forward through the AV node, to the ventricles, and back up to the atria through the accessory pathway leading to re-entry. Narrow QRS complex |
|
What is the big difference between AVRT/AVNRT and atrial tachycardia?
|
Atrial tachycardia does NOT require the AV node or the ventricles and therefore does not need a QRS associated with every P wave.
AVRT and AVNRT both require atrium, AV node, ventricles all to be functioning. |
|
What is the most common cause of atrial tachycardia?
|
Usually caused by enhanced automaticity at a focal area in the atrium - idiopathic etiology
|
|
What is the initial treatment of choice in unstable SVT?
|
Synchronized DC cardioversion
|
|
What maneuvers can aid in terminating AVRNT or AVRT in a patient?
|
Valsalva and vagal manuevers affect AV nodal conduction and abruptly terminate these arrhythmias
|
|
What can result from tachycardia induced cardiomyopathy?
|
Heart failure and death
|
|
What are ECG characteristics in atrial fibrillation?
|
Chaotic atrial activity with an irregularly irregular response
|
|
Atrial fibrillation can be characterized into three main patterns - what are they?
|
Paroxysmal - self terminating episodes <1 wk
Persistent - longer than one week, may not terminate without cardioversion permanent - present for more than one year. Refractory to cardioversion |
|
What is an example of a vagal maneuver?
|
Carotid sinus massage
|
|
A patient with SVT performs a Valsalva maneuver ("bears down") in an attempt to terminate the arrhythmia, but they are unsuccessful and the arrhythmia continues. What does this tell you? What type of SVT might this be?
|
The AV node is not in the circuit as the Valsalva would have stopped it.
This indicates the SVT is atrial tachycardia. |
|
A patient tells you they experience their SVT symptoms every day. What can you use to document the tachycardia?
|
Holter monitor - 24-48h continuous recording
If the symptoms were less often, can use event recorders (loop or non looping) |
|
What is a potential outcome in a patient with both WPW/pre-excitation AND atrial fibrillation? What is the treatment of choice for these patients?
|
Ventricular fibrillation - this is the mechanism of SCD in these patients.
Treatment of choice is catheter ablation |
|
What is the characteristic rhythm on ECG of atrial fibrillation?
|
Irregularly irregular
|
|
What is a common trigger for atrial fibrillation?
|
Rapid activity from the pulmonary veins
some AFib is related to structural heart disease: CHF, mitral valve disesase, HTN, LVH |
|
What are some electrophysiological abnormalities that can predispose a person to atrial fibrillation?
|
Fibrosis and remodeling (eg. from previous MI, previous AFib leading to dilation and fibrosis)
Cardiac ion channelopathies Atrial ectopic triggers (eg. pulmonary veins) |
|
True or false: atrial fibrillation can be present for more than a year.
|
True.
This is 'permanent atrial fibrillation' refractory to cardioversion. |
|
What are the three main goals of treatment in atrial fibrillation?
|
1) Prevent thromboembolism
2) Symptom control 3) Prevention of tachycardia induced cardiomyopathy |
|
Why are patients with atrial fibrillation predisposed to increased risk of thromboembolism?
|
The atria are not contracting properly and blood can pool and clot, most commonly in LA appendage
|
|
What groups of patients with atrial fibrillation are at higher risk for thromboembolism and should be anticoagulated with warfarin/NOA?
|
Valvular heart disease - eg. MV disease
Hypertrophic cardiomyopathy Increased risk determined by CHADSVASC score |
|
What risks are worth 1pt each in the CHADS2 score? When should they be treated with warfarin/NOA?
|
1. CHF
2. HTN 3. Age > 75 4. Diabetes 5. Prior embolization or CVA CHADS > 1, they get better risk reduction of stroke than without warfarin. |
|
What two risks must be balanced in the approach to prevention of thromboembolism in atrial fibrillation?
|
Risk of thromboembolism VS risk of intracranial hemorrhage
|
|
What is the target INR for warfarin? Why is this the target range?
|
Target INR = 2-3
This provices the lowest risk of stroke AND lowest risk of intracranial bleed |
|
True or false: rhythm control is superior to rate control in reducing mortality and risk of stroke.
|
False.
There is no evidence to support one or the other, but rate control is generally first line since it is more simple. |
|
When is rhythm control preferred in treatment of atrial fibrillation?
|
- Patients with new or highly symptomatic AF
- Limited by bradycardia May elect to do DC cardioversion or antiarrhythmic meds with these patients to promote normal rhythm |
|
What are the goals for rate control in atrial fibrillation? (resting HR, avg HR, max HR)
|
HR < 80
Avg HR < 100 No HR > 110% of max age predicted |
|
What is the mechanism of action of DC cardioversion?
|
Depolarizes all of the heart cells to allow sinus rhythm to come through
|
|
What is a pro arrhythmia?
|
The generation of a new arrhythmia from antiarrhythmic medication
|
|
True or false: atrial flutter conveys the same stroke risk as atrial fibrillation.
|
TRUE
|
|
differential for SVT
|
AT - atrial tachycardia
AVNRT - AV node reentry tachycardia AVRT - AV reentry tachycardia AFL - atrial flutter MAT - multifocal atrial tachycardia remember that the treatments for VT will work for SVT but the treatments for SVT might kill someone with VT. So when in doubt treat as VT |
|
rate control drugs for AFib?
|
bb, verapamil, diltiazem, digoxin
|
|
considerations for rhythm control?
|
LVEF
age diuretic use gender (women are more predisposed to proarrhythmia) |
|
rhythm control drugs and their classes
|
flecainide/propafenone - class 1C Na channel blockers, slows conduction)
sotalol (class 3 K channel blocker, prolongs repolarization) amiodarone (class 3 K channel blocker, BB, inotrope) |
|
when do you use which rhythm control agent
|
amiodarone in LV systolic dysfunction
sotalol or amiodarone in CAD with preserved LVEF don't use sotalol in the elderly women on diuretics (worry about hypoK) |
|
T/F rhythm control helps for symptom control and altering stroke risk
|
FALSE
rhythm control only helps for symptoms |
|
Why is AFlutter important?
|
carries the same stroke risk as AFib
|
|
both is AFlutter divided in terms of pahtophys and treatment
|
typical - saw tooth pattern in the inferior leads, rate over 300/min
atypical - everything else treatment is straightforward for typical Rf ablation (95%) success atypical flutter more like AFib |